Surgical treatment of pediatric moyamoya disease

被引：0

作者：

Rhee, Jay W. ^{[1
]}

Tork, Craig A. ^{[2
]}

Sabbag, Orlando D. ^{[3
]}

Magge, Suresh N. ^{[4
]}

机构：

[1] Georgetown Univ Hosp, Dept Neurosurg, Washington, DC USA

[2] Medstar Washington Hosp Ctr, Washington, DC USA

[3] Georgetown Univ, Sch Med, Arlington, VA USA

[4] Childrens Natl Med Ctr, Div Neurosurg, 111 Michigan Ave NW,4th Floor West Wing,Suite 100, Washington, DC 20010 USA

来源：

JOURNAL OF PEDIATRIC NEURORADIOLOGY | 2014年 / 3卷 / 01期

关键词：

Moyamoya disease; Moyamoya syndrome; Encephaloduroarteriosynangiosis; EDAS; Superficial temporal artery to middle cerebral artery bypass; pial synangiosis; stroke; ischemia;

D O I：

10.3233/PNR-14084

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Cerebral ischemia is a well-recognized cause of morbidity in the pediatric population. Moyamoya disease, first described in 1957 by Takeuchi and Shimizu, is an idiopathic chronic vasculopathy that often presents with ischemia. Moyamoya syndrome presents with similar clinical manifestations and disease progression but may occur unilaterally or in the setting of a predisposing condition. Both direct and indirect revascularization procedures have proven to be efficacious for pediatric moyamoya patients.

引用

页码：29 / 37

页数：9

共 84 条

[1] Surgical Outcomes for Moyamoya Angiopathy at Barrow Neurological Institute With Comparison of Adult Indirect Encephaloduroarteriosynangiosis Bypass, Adult Direct Superficial Temporal Artery-to-Middle Cerebral Artery Bypass, and Pediatric Bypass: 154 Revascularization Surgeries in 140 Affected Hemispheres [J].

Abla, Adib A. ;

Gandhoke, Gurpreet ;

Clark, Justin C. ;

Oppenlander, Mark E. ;

Velat, Gregory J. ;

Zabramski, Joseph M. ;

Albuquerque, Felipe C. ;

Nakaji, Peter ;

Spetzler, Robert F. ;

Wanebo, John E. .

NEUROSURGERY, 2013, 73 (03) :430-439

[2] Novel epidemiological features of moyamoya disease [J].

Baba, T. ;

Houkin, K. ;

Kuroda, S. .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (08) :900-904

[3] Moyamoya Disease in a Primarily White, Midwestern US Population Increased Prevalence of Autoimmune Disease [J].

Bower, Regina S. ;

Mallory, Grant W. ;

Nwojo, Macaulay ;

Kudva, Yogish C. ;

Flemming, Kelly D. ;

Meyer, Fredric B. .

STROKE, 2013, 44 (07) :1997-+

[4] Natural history of Moyamoya disease: comparison of activity of daily living in surgery and nonsurgery groups [J].

Choi, JU ;

Kim, DS ;

Kim, EY ;

Lee, KC .

CLINICAL NEUROLOGY AND NEUROSURGERY, 1997, 99 :S11-S18

[5]

DONAGHY RMP, 1972, SURG GYNECOL OBSTETR, V134, P269

[6] Lessons Learned From Moyamoya Disease: Outcome of Direct/Indirect Revascularization Surgery for 150 Affected Hemispheres [J].

Fujimura, Miki ;

Tominaga, Teiji .

NEUROLOGIA MEDICO-CHIRURGICA, 2012, 52 (05) :327-332

[7] Efficacy of Prophylactic Blood Pressure Lowering according to a Standardized Postoperative Management Protocol to Prevent Symptomatic Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease [J].

Fujimura, Miki ;

Inoue, Takashi ;

Shimizu, Hiroaki ;

Saito, Atsushi ;

Mugikura, Shunji ;

Tominaga, Teiji .

CEREBROVASCULAR DISEASES, 2012, 33 (05) :436-445

[8] The effectiveness of O-2 administration for transient ischemic attacks in moyamoya disease in children [J].

Fujiwara, J ;

Nakahara, S ;

Enomoto, T ;

Nakata, Y ;

Takita, H .

CHILDS NERVOUS SYSTEM, 1996, 12 (02) :69-75

[9] Moyamoya disease [J].

Fukui, M ;

Kono, S ;

Sueishi, K ;

Ikezaki, K .

NEUROPATHOLOGY, 2000, 20 :S61-S64

[10]

Fukui M, 1997, CLIN NEUROL NEUROSUR, V99, pS238

← 1 2 3 4 5 6 7 8 9 →